HearUSA to Carry Sony’s Over-the-Counter Hearing Aids

Responding to the Food and Drug Administration’s recent approval of over-the-counter (OTC) hearing aids, today HearUSA announced that it will offer Sony’s new over-the-counter hearing aids. The first two models of the over-the-counter hearing aids – the Sony CRE-C10 and Sony CRE-E10 – will be available for clients to purchase early next year in all HearUSA centers and online.

According to HearUSA President James Gilchrist, OTC hearing aids have the potential to increase the number of people who address their hearing loss by improving the overall awareness of the importance of hearing health; providing affordable access to hearing solutions for those with mild to moderate hearing loss; and empowering Americans to start their hearing health journey sooner.

Further, as a strong consumer brand, Sony will help shatter the stigma associated with hearing loss and guide more people towards better hearing health.

“Sony’s OTC hearing aids, built on their world-renowned leadership and experience in audio technology, will accelerate HearUSA’s new brand vision to bring the ‘Sound of the New Age’ to millions of new clients nationwide,” stated Gilchrist. “Sixty-five percent of the people in the United States with hearing loss do not wear hearing aids.[1] OTC hearing aids will help raise awareness about hearing health and engage more clients with an effective solution to start on the journey to better hearing health sooner – one to be guided by our hearing care professionals.”

The new Sony models – the CRE-C10 and the CRE-E10 – blend comfort and technology to reconnect consumers with mild to moderate hearing loss to what matters most[2].

HearUSA has developed a guided process to help clients discover whether they are a good candidate for OTC hearing aids based on their type and severity of hearing loss. HearUSA will educate clients on the importance of a comprehensive hearing aid evaluation and the role of hearing care professionals in diagnosing and improving their overall hearing health and wellness. Service packages will be available for OTC candidates that want the support of a hearing care professional on their hearing health journey.

Sony’s new OTC hearing aids will be available for purchase in early 2023 at HearUSA hearing centers nationally and online at the HearUSA website, where consumers will also be guided through a hearing screening and questionnaire to determine if OTC hearing aids are right for them.

“The addition of Sony’s OTC hearing aids to our already industry-leading portfolio of prescription solutions is as significant for our hearing care professionals as it is for our clients,” stated HearUSA’s Senior Director, Professional Development Sheneekra Adams, AuD. “The first step in a client’s hearing health journey should always begin with professional consultation. Now, thanks to this collaboration, our HCPs nationwide are equipped with a complete portfolio of the world’s best hearing aid solutions for all clients, across all levels of hearing loss and budget.”

The availability of the Sony models through HearUSA comes on the heels of the company’s launch of a bold new brand and brand vision – Sound of the New Age – dedicated to transforming the way hearing care is delivered in the United States.

For more information on HearUSA, visit www.hearusa.com.

[1] Quick Statistics About Hearing. (2021, March 25). www.nidcd.nih.gov. Retrieved October 11, 2022, from https://www.nidcd.nih.gov/health/statistics/quick-statistics-hearing

[2] Sony | Hearing control app – Use app on smartphone to personalize settings. Download app at Google Play and the App Store. Network services, content, and operating system and software subject to terms and conditions and may be changed, interrupted or discontinued at any time and may require registration.

SourceHearUSA
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version